Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
In Kyung Jung
Institution:
Cellid (South Korea)
Observed institution:
Cellid (South Korea)
ORCID:
0000-0003-1502-3187
Observed ORCID:
0000-0003-1502-3187
OpenAlex ID:
A5103047835
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform
2024
·
Soojeong Chang
, Kwang-Soo Shin
, et al.
·
Proceedings of the National Academy of Sciences
·
18
Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice
2023
·
Kwang-Soo Shin
, Byung-Seok Kim
, et al.
·
International Journal of Antimicrobial Agents
·
6
Continuous Tracking for Effective Tackling: Ad5/35 Platform‐Based JN1 Lineage Vaccines Development in Response to Evolving SARS‐CoV‐2 Variants
2025
·
Soojeong Chang
, Jieun Shin
, et al.
·
Journal of Medical Virology
·
3
Development of broadly protective COVID-19 vaccine against up-to-date variants based on adenovirus type 5/35 vector platform
2023
·
Chang-Yuil Kang
, Soojeong Chang
, et al.
·
The Journal of Immunology
·
1
PDF
The Ad5/35 Platform-Based Vaccines for SARS-CoV-2: A Strategy to Counter Evolving Variants 2324
2025
·
Chang-Yuil Kang
, Soojeong Chang
, et al.
·
The Journal of Immunology
PDF
Show more works
View as search
Works count:
5
Citation count:
28
H-index:
3
I10-index:
1
Year
Topic
Type
